BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 8454456)

  • 1. Management of congestive heart failure: neuroendocrine approach.
    Shmuely H; Sclarovsky S; Rosenfeld JB
    Isr J Med Sci; 1993 Jan; 29(1):6-10. PubMed ID: 8454456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure.
    van Zwieten PA
    Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure].
    Peruzzi G; Di Nardo P; Raimondi G; Legramante JM; Iellamo F; Massaro M; Bellegrandi F; Minieri M; Pafi M; Castrucci F
    Clin Ter; 1992 Nov; 141(11):339-72. PubMed ID: 1493659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatment of heart insufficiency].
    Follath F
    Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of left heart failure with reference to hemodynamic and neurohumoral changes].
    Schmieder RE
    Acta Med Austriaca; 1992; 19(3):77-82. PubMed ID: 1357906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure. Drug therapy: central or peripheral approach?
    Remme WJ
    Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure: pathophysiology and management with special reference to systemic hypertension.
    Visser FC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S8-11. PubMed ID: 1721986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral adaptation in chronic heart failure: therapeutic implications].
    Drexler H
    Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of congestive heart failure: is the role of positive inotropic therapy fading?
    Futterman LG; Lemberg L
    Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.